Details for New Drug Application (NDA): 087958
✉ Email this page to a colleague
NDA 087958 describes HEPARIN LOCK FLUSH, which is a drug marketed by Hospira, Intl Medication, Luitpold, Parke Davis, Smith And Nephew, and Solopak, and is included in seventeen NDAs. Additional details are available on the HEPARIN LOCK FLUSH profile page.
The generic ingredient in HEPARIN LOCK FLUSH is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
The generic ingredient in HEPARIN LOCK FLUSH is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
Summary for 087958
| Tradename: | HEPARIN LOCK FLUSH |
| Applicant: | Smith And Nephew |
| Ingredient: | heparin sodium |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10 UNITS/ML | ||||
| Approval Date: | Apr 20, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
